These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22595307)

  • 21. Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Yamaguchi K
    J Virol Methods; 2006 Sep; 136(1-2):254-6. PubMed ID: 16707169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples.
    Servant-Delmas A; Mercier-Darty M; Ly TD; Wind F; Alloui C; Sureau C; Laperche S
    J Clin Virol; 2012 Apr; 53(4):338-45. PubMed ID: 22296790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance evaluation of new automated hepatitis B viral markers in the clinical laboratory: two quantitative hepatitis B surface antigen assays and an HBV core-related antigen assay.
    Park Y; Hong DJ; Shin S; Cho Y; Kim HS
    Am J Clin Pathol; 2012 May; 137(5):770-7. PubMed ID: 22523216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection.
    Svicher V; Cento V; Bernassola M; Neumann-Fraune M; Van Hemert F; Chen M; Salpini R; Liu C; Longo R; Visca M; Romano S; Micheli V; Bertoli A; Gori C; Ceccherini-Silberstein F; Sarrecchia C; Andreoni M; Angelico M; Ursitti A; Spanò A; Zhang JM; Verheyen J; Cappiello G; Perno CF
    Antiviral Res; 2012 Jan; 93(1):86-93. PubMed ID: 22086128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.
    Jeantet D; Chemin I; Mandrand B; Tran A; Zoulim F; Merle P; Trepo C; Kay A
    J Med Virol; 2004 Aug; 73(4):508-15. PubMed ID: 15221893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
    Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
    Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. European collaborative evaluation of the Enzygnost HBsAg 6.0 assay: performance on hepatitis B virus surface antigen variants.
    Avellón A; Echevarría JM; Weber B; Weik M; Schobel U; Willems WR; Gerlich WH
    J Med Virol; 2011 Jan; 83(1):95-100. PubMed ID: 21108344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection.
    Scheiblauer H; Soboll H; Nick S
    J Med Virol; 2006; 78 Suppl 1():S66-70. PubMed ID: 16622881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays.
    Ireland JH; O'Donnell B; Basuni AA; Kean JD; Wallace LA; Lau GK; Carman WF
    Hepatology; 2000 May; 31(5):1176-82. PubMed ID: 10796895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance characteristics of an improved version of the ABBOTT IMx HBsAg (V2) MEIA.
    Pfeifer K; Dobson C; Herron A; Kapprell HP
    Clin Lab; 2002; 48(7-8):359-64. PubMed ID: 12146568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and preliminary applications of hepatitis B surface antigen mutants].
    Zhu CC; Luo CZ; Wang M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1136-9. PubMed ID: 18062886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of a novel HBsAg quantitative assay].
    Takagi K; Tanaka Y; Naganuma H; Hiramatsu K; Iida T; Takasaka Y; Mizokami M
    Rinsho Byori; 2007 Jul; 55(7):619-25. PubMed ID: 17718057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene.
    Weber B
    J Med Virol; 2006; 78 Suppl 1():S59-65. PubMed ID: 16622880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of HBsAg mutants.
    Osiowy C
    J Med Virol; 2006; 78 Suppl 1():S48-51. PubMed ID: 16622877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
    Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy.
    Cheung WI; Chan HL; Leung VK; Tse CH; Fung K; Lin SY; Wong A; Wong VW; Chau TN
    J Clin Virol; 2010 Feb; 47(2):193-5. PubMed ID: 20031483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples.
    Linauts S; Saldanha J; Strong DM
    Transfusion; 2008 Jul; 48(7):1376-82. PubMed ID: 18422847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.